Literature DB >> 18230043

High prevalence of peripheral arterial disease in HIV-infected persons.

Daniel Periard1, Matthias Cavassini, Patrick Taffé, Melanie Chevalley, Laurence Senn, Caroline Chapuis-Taillard, Serge de Vallière, Daniel Hayoz, Philip E Tarr.   

Abstract

BACKGROUND: Atherosclerosis has been assessed in human immunodeficiency virus (HIV)-infected persons by using various methods. Peripheral arterial disease (PAD) has not been evaluated, however. We studied the cross-sectional prevalence of lower limb PAD in an HIV-infected population.
METHODS: PAD was assessed using the Edinburgh Claudication Questionnaire and by measuring the systolic ankle-brachial blood pressure index (ABI) at rest and after exercise. Patients with PAD were further evaluated by duplex scan of lower limb arteries.
RESULTS: Ninety-two consecutive HIV-infected patients were evaluated (23.9% women; mean age, 49.5 years; 61.9% current smokers). Claudication was reported by 15.2% of the patients. PAD was found in 20.7% of the patients: 9.8% had an abnormal ABI (<0.90) at rest, and 10.9% had normal ABI at rest but a >25% decrease after exercise. Of the patients with PAD, 84.2% were investigated with duplex scan, all of whom had atherosclerotic occlusions or stenoses of the iliac or femoral arteries. Age, diabetes, smoking, and low CD4+ T lymphocyte counts were identified as independent predictors of PAD.
CONCLUSIONS: The prevalence of symptomatic and asymptomatic PAD is high in the HIV-infected population and is much higher than expected (prevalence in the general population, approximately 3% at 60 years). This study suggests the presence of an epidemic of PAD approximately 20 years earlier in the HIV-infected than in the general population. Larger epidemiological studies are needed to better define risk factors and to evaluate whether PAD is associated with increased mortality, as it is in the general population.

Entities:  

Mesh:

Year:  2008        PMID: 18230043     DOI: 10.1086/527564

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

1.  Early atherosclerosis in HIV-infected patients below the age of 55 years: Slovenian national study.

Authors:  Mateja Pirs; Barbara Eržen; Mišo Sabović; Primož Karner; Ludvik Vidmar; Mario Poljak; Borut Jug; Mojca Mikac; Janez Tomažič
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

2.  Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.

Authors:  Homer L Twigg; Ronald Crystal; Judith Currier; Paul Ridker; Nancy Berliner; Hans-Peter Kiem; George Rutherford; Shimian Zou; Simone Glynn; Renee Wong; Emmanuel Peprah; Michael Engelgau; Tony Creazzo; Sandra Colombini-Hatch; Elisabet Caler
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

Review 3.  HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.

Authors:  Revery P Barnes; John Charles A Lacson; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

4.  An unexpected cause of digital gangrene: HIV associated peripheral arterial thrombosis.

Authors:  Ayodeji O Olubaniyi; Charlotte-Eve Short; Denis Remedios; Moses Kapembwa
Journal:  Br J Gen Pract       Date:  2013-03       Impact factor: 5.386

Review 5.  Lipid Abnormalities and Inflammation in HIV Inflection.

Authors:  Nicholas T Funderburg; Nehal N Mehta
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

6.  Replication of RYR3 gene polymorphism association with cIMT among HIV-infected whites.

Authors:  Sadeep Shrestha; Qi Yan; Gregory Joseph; Donna K Arnett; Jeremy J Martinson; Lawrence A Kingsley
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 7.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

8.  A genome-wide association study of carotid atherosclerosis in HIV-infected men.

Authors:  Sadeep Shrestha; Marguerite R Irvin; Kent D Taylor; Howard W Wiener; Nicholas M Pajewski; Talin Haritunians; Joseph A C Delaney; Morris Schambelan; Joseph F Polak; Donna K Arnett; Yii-Der Ida Chen; Carl Grunfeld
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

9.  Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Authors:  Margalida Rotger; Tracy R Glass; Thomas Junier; Jens Lundgren; James D Neaton; Estella S Poloni; Angélique B van 't Wout; Rubin Lubomirov; Sara Colombo; Raquel Martinez; Andri Rauch; Huldrych F Günthard; Jacqueline Neuhaus; Deborah Wentworth; Danielle van Manen; Luuk A Gras; Hanneke Schuitemaker; Laura Albini; Carlo Torti; Lisa P Jacobson; Xiuhong Li; Lawrence A Kingsley; Federica Carli; Giovanni Guaraldi; Emily S Ford; Irini Sereti; Colleen Hadigan; Esteban Martinez; Mireia Arnedo; Lander Egaña-Gorroño; Jose M Gatell; Matthew Law; Courtney Bendall; Kathy Petoumenos; Jürgen Rockstroh; Jan-Christian Wasmuth; Kabeya Kabamba; Marc Delforge; Stephane De Wit; Florian Berger; Stefan Mauss; Mariana de Paz Sierra; Marcelo Losso; Waldo H Belloso; Maria Leyes; Antoni Campins; Annalisa Mondi; Andrea De Luca; Ignacio Bernardino; Mónica Barriuso-Iglesias; Ana Torrecilla-Rodriguez; Juan Gonzalez-Garcia; José R Arribas; Iuri Fanti; Silvia Gel; Jordi Puig; Eugenia Negredo; Mar Gutierrez; Pere Domingo; Julia Fischer; Gerd Fätkenheuer; Carlos Alonso-Villaverde; Alan Macken; James Woo; Tara McGinty; Patrick Mallon; Alexandra Mangili; Sally Skinner; Christine A Wanke; Peter Reiss; Rainer Weber; Heiner C Bucher; Jacques Fellay; Amalio Telenti; Philip E Tarr
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

10.  Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study.

Authors:  James J Jang; Aron I Schwarcz; Daniel A Amaez; Mark Woodward; Jeffrey W Olin; Marla J Keller; Alison D Schecter
Journal:  J Int AIDS Soc       Date:  2010-03-22       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.